Research Insight
Research Insight
Mauna Kea Technologies Announces New Clinical Study and Research Collaboration Agreement with the Lung Cancer Initiative at Johnson & Johnson
Mauna Kea Technologies, inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, announced that it has entered into a new research collaboration agreement with the Lung Cancer Initiative at Johnson & Johnson1 to advance the validation...
Research Insight
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program will explore the role of extrachromosomal DNA in cancer and it will complement the research...
Research Insight
Medtronic InPen RWD and Extended Infusion Set Pivotal Trial Results Demonstrate Strong Clinical Outcomes and Positive User Experience
Medtronic plc, the global leader in medical technology, announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The presentations illustrated increases in Time in Range when using an InPen™ smart insulin pen, safety of...
Research Insight
The Science of Lung-Gut-Brain Axis in Fighting COVID-19
COVID-19 has, rightfully so, brought a lot of attention to the health of our lungs. We are thinking of increasing - even if not practising regularly - pranayam, yog, neti. We are even taking in zinc and vitamin D...
Research Insight
A ‘Single Dose’ of vaccine sufficient for those already infected with COVID-19, says AIG Study
During the second COVID wave when cases were growing exponentially; unfortunately, the vaccination rate took a downturn. As of 27th April, when the growth rate of active infection was ~5% and the growth of vaccinated people was just 1.4%....
Research Insight
Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities
A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase. These biochemical abnormalities, identified by a...
Research Insight
BostonGene Announces Cancer Research Collaboration with the Abramson Cancer Center of the University of Pennsylvania
BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, announced a Master Clinical Research Collaboration Agreement with the Abramson Cancer Center (ACC) of the University of Pennsylvania to support multiple research projects...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read